CONDENSED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 3,241,440	$ 4,145,735
Prepaid expenses	549,835	520,368
Supplies used for R&D and manufacturing	2,347,049	2,248,072
Deposits	16,129	4,245
Total current assets	6,154,453	6,918,420
Finance lease right of use assets	8,680,732	9,131,987
Operating lease right of use assets	1,649,020	1,698,243
Property and equipment, net	9,644,158	10,188,126
Patent costs, net	188,294	197,704
Deposits	2,319,101	2,319,101
Supplies used for R&D and manufacturing	74,457	74,669
Total assets	28,710,215	30,528,250
Current liabilities:
Accounts payable	1,144,425	2,009,786
Accrued expenses	985,657	1,049,581
Due to employees	705,698	557,244
Finance lease obligation, current portion	1,827,363	1,771,804
Operating lease obligation, current portion	204,167	197,431
Total current liabilities	4,867,310	5,585,846
Finance lease obligations, net of current portion	9,468,149	9,949,565
Operating lease obligations, net of current portion	1,599,496	1,652,949
Other liabilities	125,000	125,000
Total liabilities	16,059,955	17,313,360
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value; 200,000 shares authorized; 0 shares issued and outstanding	0	0
Common stock, $.01 par value; 600,000,000 shares authorized; 50,018,601 and 47,422,304 shares issued and outstanding at December 31, 2023 and September 30, 2023, respectively	500,186	474,223
Additional paid-in capital	505,950,994	499,832,063
Accumulated deficit	(493,800,920)	(487,091,396)
Total stockholders' equity	12,650,260	13,214,890
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 28,710,215	$ 30,528,250